Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Looking for short term gigs? Discover where to find quick cash options that fit your schedule.
25,797 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
XRP is facing renewed selling pressure across major trading pairs, with a looming test of the $1.20 support and criti...
Constellation Energy will release its annual guidance in March, but its shares rose to a six-week high on Tuesday as ...
CoreCivic has faced a share-price headwind even as revenue climbs. A notable $5 million stake by Hahn Capital signals...
CrowdStrike delivered a record Q4 with key ARR milestones, prompting mixed but bullish reactions from four top banks....
Novo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
Beachbody's 2025 earnings shed light on how fitness brands monetize digital subscriptions, gear, and licensing. This ...
U.S. drone output is under scrutiny as manufacturers push for scale. Red Cat and AeroVironment highlight a market shi...
Can a $5,000 investment unlock big potential in quantum computing stocks? This guide breaks down the landscape, insid...
A powerful, data-driven case for why the healthcare stock rebound 2026 is more than a rumor. Learn how to spot streng...
A missile strike on Qatar’s LNG facilities pushes oil and gas markets higher. Traders point to wall street buying the...
Viomi (VIOT) 2025 earnings are shaping up as a pivotal moment for this IoT home player. This guide breaks down what t...